Written by Alex on May 22, 2009 – 12:01 pm
Lilly drug heads to trials’ 3rd phase – Indianapolis Star – United States, Indianapolis – A third set of clinical trials for a possible Alzheimer’s treatment is about to get under way, Eli Lilly and Co. said Thursday … See all stories on this topic
Cholesterol drug cuts amputation risk for diabetics – Reuters – USA – … led by Anthony Keech and Kushwin Rajamani at the National Health and Medical Research Council Clinical Trials Center, University of Sydney, Australia. … See all stories on this topic
Study finds most clinical trials use erroneous data – Healthcare Republic – USA – Calculations of sample size are correctly reported in just one in three clinical trial publications, according to new research … – See all stories on this topic
Sanofi-Aventis Discontinues 14 Drugs in Clinical Trials – FDA news (subscription) – Falls Church, VA, USA – Development of 14 Sanofi-Aventis drugs already in clinical trials is being shut down following a company review of its R&D portfolio … See all stories on this topic
Researchers Start New Anti-Cancer Drug Trial – eMaxHealth.com – Hickory, NC, USA – Cancer Research UK and Cancer Research Technology (CRT) today announced they will begin a phase 1 clinical trial of an anti-cancer drug from GlaxoSmithKline … See all stories on this topic
polymedix Receives Regulatory Clearance to Initiate Second Phase I … Business Wire (press release) – San Francisco, CA, USA – This second Phase I clinical trial will assess the safety of PMX-30063 given repeatedly over a period of several days. Healthy volunteers will each receive … See all stories on this topic
Lilly starts big studies for Alzheimer’s candidate – Reuters – USA – … said on Thursday that it had advanced a second experimental treatment for Alzheimer’s disease into late-stage clinical trials … See all stories on this topic
Avid Radiopharmaceuticals Closes $34.5 Million Series D Financing – Business Wire (press release) – San Francisco, CA, USA – “Avid made tremendous progress through its clinical trials since our last fundraising in May 2007,” said Daniel M. Skovronsky, MD, Ph.D., Founder and CEO of … See all stories on this topic
Lilly Advances Second Alzheimer’s Disease Treatment Candidate Into … PR Newswire (press release) – New York, NY, USA – In 2008, Lilly began enrolling patients in two Phase III clinical trials called IDENTITY and IDENTITY 2 for a different potential treatment for Alzheimer’s … See all stories on this topic
It is important for patients and families affected by diseases such as Alzheimer’s to consider participating in clinical studies. Another study to consider is the ICARA (Bapi) Study (www.icarastudy.com), whose goal is to explore if an investigational drug, called Bapineuzumab, can help slow the progression of Alzheimer’s Disease. Clinical studies that test new treatments are the best chance we have for fighting this disease. Current therapies for Alzheimer’s treat the symptoms associated with it, not the disease itself.
Thank you for pointing out that medications for Alzheimer’s treat symptoms at this point. That’s an important distinction and a good rationale to explore trials as a way to finally address the causes and possible cures.